DACOMITINIB

Daclizumab is a monoclonal antibody targeting IL2 receptors, used in transplant rejection prevention. Side effects include infections, liver dysfunction, and skin reactions. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 38d57b42610d Category: Tag:

Product Description


Mechanism of Action

Dacomitinib is an irreversible, panErbB tyrosinekinase inhibitor that covalently binds to EGFR, HER2, and HER4. By blocking ATP binding, it shuts down downstream MAPK/ERK and PI3K/AKT signalling, leading to reduced tumour-cell proliferation, survival, and metastasis. Unlike reversible TKIs, its covalent bond maintains prolonged pathway suppression.

Benefits and Advantages

Used in EGFRmutant cancer research, panHER pathway modelling, resistance mechanism studies (e.g., T790M, C797S), kinaseinhibitor SAR profiling, and receptordimerisation assays.

Side Effects and Risks

Risks include severe dermatologic toxicity, diarrhea, hepatotoxicity, stomatitis, interstitial lung disease and ocular irritation. Handle under advanced kinaseinhibitor cytotoxic precautions.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C24H25ClFN5O2

Molecular Weight

469.9 g/mol

CAS Number

1110813-31-4

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

<1 mg/mL

Purity

Purity information is available upon request (COA).

Synonym

Dacomitinib; 1110813-31-4; PF-00299804; Dacomitinib anhydrous; Vizimpro

IUPAC/Chemical Name

(E)-N-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]-4-piperidin-1-ylbut-2-enamide

InChl Key

LVXJQMNHJWSHET-AATRIKPKSA-N

InChl Code

InChI=1S/C24H25ClFN5O2/c1-33-22-14-20-17(24(28-15-27-20)29-16-7-8-19(26)18(25)12-16)13-21(22)30-23(32)6-5-11-31-9-3-2-4-10-31/h5-8,12-15H,2-4,9-11H2,1H3,(H,30,32)(H,27,28,29)/b6-5+

References

https://pubchem.ncbi.nlm.nih.gov/compound/11511120;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download